ImYoo

ImYoo

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.imyoo.health/

Last Round

Accelerator

Dec 2, 2024

Total Funding Raised

$100,000

Momentum Score

25 /100

Company Overview

ImYoo is a biotechnology company that provides a patient-enabled biodiscovery platform for at-home blood sample collection and single-cell multi-omic analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS, Revenue Share

AI Layer

Application

Keywords

biodiscovery platformat-home blood collectionmulti-omicssingle-cell analysislongitudinal datascRNA-seqbiomarker discoverypatient stratificationdecentralized clinical trialsAI drug discoveryclinical trial supportprecision medicineautoimmune diseasebiological digital twinimmune atlaspatient-centric research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImYoo Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ImYoo Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 2, 2024
SeedJul 31, 2022

Key People

Founding team and executive leadership

David Brown

CTO Co-founder

Founding Team

Tatyana Dobreva

Chief Executive Officer

Executive Team

ImYoo Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 19, 2025

    Grew 43% QoQ from 7 to 10 employees.

  • Dec 2, 2024

    $100K raised from Merck and NJII.

ImYoo Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ImYoo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImYoo's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range11
Year FoundedN/A
Last FundingDec 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.